Therapist Adherence to Cognitive-behavioral Therapy

Overview

An observational web-based survey on therapist adherence to evidence-based cognitive-behavioral therapy (CBT) in the perspective of their patients with depression or anxiety disorders in psychiatric outpatient care in Stockholm, Sweden. Following completion of CBT, participants respond to questions including their age, gender, education, whether they have improved, whether they considered treatment helpful, and an instrument measuring therapist adherence to CBT procedures (e.g., setting agenda, follow up on home assignments) and CBT techniques (e.g., exposure, cognitive restructuring). The purpose of the study is to contribute to quality assurance of CBT in Stockholm Health Care Services.

Full Title of Study: “Therapist Adherence to Evidence-based Cognitive-behavioral Therapy in a Patient Perspective”

Study Type

  • Study Type: Observational [Patient Registry]
  • Study Design
    • Time Perspective: Cross-Sectional
  • Study Primary Completion Date: June 30, 2023

Interventions

  • Behavioral: Cognitive-behavioral therapy
    • Cognitive-behavioral therapy including both behavioral and cognitive interventions.

Arms, Groups and Cohorts

  • Psychiatric patients
    • Psychiatric outpatient care patients with major depressive disorder, anxiety disorders, post-traumatic stress disorder, obsessive-compulsive disorder, or illness anxiety disorder who have just completed cognitive-behavioral therapy.

Clinical Trial Outcome Measures

Primary Measures

  • Adherence to Cognitive-Behavioral Therapy Scale – Patient Version
    • Time Frame: Up to 20 weeks
    • Patients rate the degree to which therapists adhere to evidence-based cognitive-behavioral therapy procedures and techniques on a Likert-type scale from 0 (Not at all) to 4 (To a very high degree)

Participating in This Clinical Trial

Inclusion Criteria

  • A primary diagnosis of major depressive disorder, social anxiety disorder, panic disorder, agoraphobia, generalized anxiety disorder, obsessive-compulsive disorder, post-traumatic stress disorder, or illness anxiety disorder – 18 years of age or older – Just completed individual cognitive-behavioral therapy in psychiatric outpatient care in Stockholm, Sweden Exclusion Criteria:

  • None

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Karolinska Institutet
  • Provider of Information About this Clinical Study
    • Principal Investigator: Benjamin Bohman, Principal Investigator – Karolinska Institutet
  • Overall Official(s)
    • Benjamin Bohman, Principal Investigator, Karolinska Institutet

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.